Contributes to the development of the pharmaceutical industry by providing high-quality and prompt services.
The Healthcare Business Div. contributes to the development of the pharmaceutical industry by providing high-quality and prompt services to our customers through the domestic and overseas network of Mitsui Group.
According to the customer’s requirements, we select the most suitable company from our domestic and overseas business partners and provide total coordination of the business of export, import, import agency, and domestic sales of pharmaceutical raw materials, APIs, and intermediates. We constantly provide the latest market information, not only through our own information network, but also by utilizing the overseas networks and assets of Mitsui Group. We focus on building new business by responding quickly and finely to the needs of each customer.
In addition to our existing logistics business, we also utilize our strong relationships with overseas contract manufacturers, mainly in Europe, India, and China, to provide integrated support from the development of pharmaceutical raw materials and APIs to the launch of commercial products, quality control, and response to pharmaceutical issues.
We support the domestic and overseas development of STEBORONINE for infusion, a cancer treatment/BNCT formulation developed by Japanese pharmaceutical manufacturer STELLA PHARMA CORPORATION, received approval for drug manufacturing and marketing by PMDA in May 2020, and listed it on the National Health Insurance (NHI) Drug Price List. Through the network of Mitsui Group, we conduct negotiations with domestic and overseas medical institutions and pharmaceutical companies, and provide logistics support from Japan to the local market as well.
We provide comprehensive support from the discovery of excellent suppliers of agrochemical intermediates mainly in Asia to stable supply. Through our own network, we research the markets, regulations, and needs of each country, and support the discovery, supply, and logistics of the most suitable raw materials for each region.
Contact
Healthcare Business Div.
Solvents
Toluene / Xylene
Urethane materials
Paints and inks
Pharmaceutical raw materials
Petroleum-derived chemical raw materials
Plant-derived raw materials
Electronics & Electrical Raw Materials
Additives and raw materials for additives
Printing and adhesive
related products
Battery-related products
Electronic Materials
Recyclable goods
Bioapatite
L8020
ADINS (PFAS-compliant flame-retardant aid)